Lumexa Imaging Holdings Inc (LMRI) financials
Lumexa Imaging revenue and earnings by year
Lumexa Imaging's revenue was $1.02 billion in the fiscal year to December 31, 2025, up 7.8% from the year before. Net income was -$47.1 million, -4.6% of revenue.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 3 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 1.02 | 0.95 | 0.94 |
| Revenue growth | 7.8% | 1.4% | — |
| Gross profit | 0.16 | 0.10 | 0.10 |
| Gross margin | 15.4% | 10.1% | 10.6% |
| Operating income | 0.03 | -0.02 | -0.03 |
| Operating margin | 2.5% | -1.7% | -3.5% |
| Net income | -0.05 | -0.09 | -0.12 |
| Net margin | -4.6% | -9.9% | -13.1% |
| Free cash flow | -0.00 | 0.01 | 0.01 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open LMRI in Markets.
See also:
No forecast, no recommendation. This page describes Lumexa Imaging Holdings Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.